Neurovascular Intervention Market to Amount to USD 4 Billion by 2022, Forecasts DPI Research in Its New Report Available at MarketPublishers.com

Increasing prevalence of the cerebrovascular disease along with risk factors associated with it, population ageing and establishment of appropriate reimbursement are some of factors encouraging growth of the neurovascular intervention marketplace.

As a result, this market is expected to reach a value of approximately USD 4 billion by 2022.

The value will be higher if existing restraints are eliminated. Some of such restraints comprise a high cost of treatment, a lack of skilled neurosurgeons, unmet needs, and more.

The USA reins the global market, but such emerging economies like China, Japan and India are set to show the swiftest growth in the upcoming years.

Growth in APAC will mainly stem from improvements in healthcare facilities, rising government investment and GDP.

Coil forms the largest single category of products on the basis of device. This segment has been witnessing slowdown of its growth over the recent years, with microwire/catheter, clot removal devices and carotid stents taking the lead. However, coil is unlikely to be dethroned in the upcoming years.

When it comes to companies, the market is ruled by Medtronic, Stryker, Terumo, and more.

New research report “Neurovascular Intervention Market Size, Market Share, Disease Analysis, Major Market Outlook, Product Analysis, Price Trend, Competitive Strategies and Forecast,2016 to 2021” worked out by DPI Research & Marketing Solutions offers a comprehensive guide to the world’s neurovascular intervention marketplace. The study provides a 360-degree overview of the global market. It contains a thorough overview of major devices and sheds light on revenue for each of them.

The report explores major country markets like the USA, France, Brazil, Spain, the UK, and more. The research study segments the marketplace on the basis of diseases and covers pricing trends. It concentrates on major products and throws light on M&A deals.

The research report delves deep into the competition in this space and analyses forces driving the marketplace or challenging it. Company profiles and future projections are also available in the study.

More new reports by DPI Research can be found at its page.

CONTACTS

The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
ps@marketpublishers.com
MarketPublishers.com

Neuromodulation Market to Surpass the USD 5 Bn Mark by 2022, Expects DPI Research in Its New Report Available at MarketPublishers.com

The world’s neuromodulation market is set to surpass the USD 5 billion mark by 2022. This growth will stem from such factors as the rising prevalence of neuromodulation disease, growth in the geriatric population as well as the strong product pipeline that market players offer to their customers.

Social issues and a high cost of treatment are some of factors retraining this growth. North America is a renowned market leader amongst leaders. Europe and APAC are also in the top tree.

The APAC marketplace is slated to grow at the highest rate, and China, India and Japan will be major igniters.

Spinal cord stimulation forms the largest segment in this marketplace but it will be gradually losing its position in the upcoming years given an increase expected to take place in the deep brain stimulation segment. The latter own is forecast to become an owner of an approximately 20% share by 2022.

In terms of application, chronic pain leads the race. UFI and refractory epilepsy are other leading segments.

New research report “Neuromodulation Market (By Application, Technology, Region and Company) and Forecast to 2021 – Global Analysis” worked out by DPI Research & Marketing Solutions offers a comprehensive discussion of the global neuromodulation marketplace. The study comprehensively analyses the market space on the basis of technology. Then it proceeds with the examination of marketplace on the basis of application fields.

Regional performance is canvassed in the research report, too. The study scrutinizes the competitive situation and limelights driving forces. It throws light on challenges of the marketplace, as well. The report contains historical data and future projections thus covering the period 2010-2021 in detail.

Report Highlights:

  • all-round overview of the marketplace;
  • coverage of driving forces, challenges and opportunities;
  • insights into the performance of this market;
  • investigation of the competitive environment and players’ profiles;
  • forecast figures;
  • and more.

More new reports by our partner can be found at its page.

CONTACTS

The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
ps@marketpublishers.com
MarketPublishers.com

The global neuromodulation market is anticipated to hit more than $5 billion by 2020, according to a WiseGuyReports analysis.

http://www.beckersspine.com/orthopedic-a-spine-device-a-implant-news/item/33518-medtronic-boston-scientific-lead-neuromodulation-market-8-observations.html

The global neuromodulation market is anticipated to hit more than $5 billion by 2020, according to a WiseGuyReports analysis.

Here are eight observations:

1. An increasing geriatric population and a growing number of neurological disease cases are spurring market growth.

2. Also, development of more minimally invasive techniques will boost the market.

3. The costliness of treatment and some unfavorable social perception will hinder the neuromodulation market growth, however.

4. In 2015, North America led the neuromodulation market, with Europe and the Asia-Pacific region following.

5. India, China and Japan will witness significant growth to 2021, with increased revenues for neuromodulation device manufacturers.

6. The spinal cord stimulation segment captured the largest market share in 2015. However, the deep brain stimulation segment is expected to grow at a faster rate to 2021, accounting for a 20 percent market share by 2021.

7. Chronic pain accounts for the largest application segment of the neuromodulation market.

8. Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro lead the market.

 

More articles on devices:
NuVasive names

Medtronic, Boston Scientific lead neuromodulation market: 8 observations

http://www.beckersspine.com/orthopedic-a-spine-device-a-implant-news/item/33518-medtronic-boston-scientific-lead-neuromodulation-market-8-observations.html

The global neuromodulation market is anticipated to hit more than $5 billion by 2020, according to a WiseGuyReports analysis.

Here are eight observations:

1. An increasing geriatric population and a growing number of neurological disease cases are spurring market growth.

2. Also, development of more minimally invasive techniques will boost the market.

3. The costliness of treatment and some unfavorable social perception will hinder the neuromodulation market growth, however.

4. In 2015, North America led the neuromodulation market, with Europe and the Asia-Pacific region following.

5. India, China and Japan will witness significant growth to 2021, with increased revenues for neuromodulation device manufacturers.

6. The spinal cord stimulation segment captured the largest market share in 2015. However, the deep brain stimulation segment is expected to grow at a faster rate to 2021, accounting for a 20 percent market share by 2021.

7. Chronic pain accounts for the largest application segment of the neuromodulation market.

8. Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro lead the market.

 

Neurovascular Intervention Market Size – DPI Research

The Global market for Neurovascular Intervention is projected to reach nearly US$4 Billion by the end of 2021 growing at a CAGR of around XX% from 2016 to 2021.

Market growth can be attributed to factors such as rising prevalence of cerebrovascular disease and its associated risk factors, rise in the number of aging population, increasing knowledge of the symptoms of aneurysms and related diseases among patients, next generation of device platforms enters the market, long-term clinical data become available, appropriate treatment guidelines and reimbursement rates are established. Rapid advances in the field of neurovascular interventions and development of minimally invasive techniques have greatly expanded the market. High cost of treatment, unmet needs, scarcity of skilled neurosurgeons is restraining the growth of neurovascular interventional market.

United States is seen as the dominant player in the neurovascular intervention market. Emerging economies of India, China and Japan in the Asia-Pacific region and Latin American countries such as Brazil is slated to witness the highest growth in the forecasted period. The growth of the Asia-Pacific market is driven by improving healthcare facilities, gross domestic product (GDP) and increasing government investment.

On the basis of device,Coil represented the largest single category of products and accounted for XX% share in 2015. However, growth rate has slowed down in the segment which is being challenged by the emerging Carotid Stent, Microwire/Catheter and Clot Removal device. These three major devices grabbed the market share of XX% in 2015. It is expected that Coil will lead the neurovascular intervention market with XX% market share by the end of 2021.

Further, prudent analysis has been done on the competitor’s part, where four major players grab XX% of the global market by revenue. Stryker, Medtronic, Terumo, and DePuy Synthes are the key influencers with their products in the Neurovascular Intervention market. New releases, merger & acquisitions, collaborations and extending distribution networks are few important factors for their dominance.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, diseases, geographies, companies, price trend, pipeline products, type of devices and competitive landscape. The report concludes with the profiles of major players in the global neurovascular intervention market such as Stryker, Medtronic, Terumo, and DePuy Synthes. The major market players are evaluated on various parameters such as company overview, product portfolio, and revenue of neurovascular intervention segment from 2012 to 2021.The report also entails major drivers and challenges of neurovascular intervention market.

The report covers in–depth analysis on:

  • Market Segments
  • Market Dynamics
  • Historical Actual Market Size, 2009 – 2015
  • Market Size & Forecast 2016 to 2021
  • Competition & Companies involved
  • Merger & Acquisitions
  • Price Trend
  • Pipeline Products Analysis
  • Market Growth Drivers and Challenges

Neurovascular Intervention Market: Segmentation

Neurovascular Interventional market is classified on the basis of device type, disease type, company and geography.

Based on Device, the global neurovascular intervention market can be segmented as follows:

  • Coil
  • Carotid Stent
  • Clot Removal
  • Liquid Embolic
  • Coil Assist Balloon
  • Coil Assist Stent
  • Flow Diverter Stent
  • Micro wire/Catheter

Based on Disease, the global neurovascular intervention market can be segmented as follows:

  • Aneurysm
  • Intracranial Atherosclerotic Disease (ICAD)
  • Ischemic Stroke
  • Arteriovenous Malformation(AVM)

Based on Geography, the global neurovascular intervention market can be segmented as follows:

 

  • United States
  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Japan
  • China
  • India
  • Brazil

Based on Company, the global neurovascular intervention market can be segmented as follows:

  • Stryker
  • Medtronic
  • MicroVention (Terumo Corporation)
  • De Puy Synthes

Lab Automation Market to Reach Over USD 16 Billion in 2022

Underpinned by technology advancements, modern automated systems are already adept of a broad set of functions that have been previously carried out by manual, tedious labour. Instrumentation keeps on developing and is poised to perform tasks that were not even imaginable just some years ago. Initially used mostly by the big pharma and biotech companies, lab automation technology has evolved fast to satisfy a larger group of clinical experts in the life sciences field. Besides producing automation for particular customer needs, automation companies also make easy-to-use, smaller systems that are far more accessible to clinical experts to comply with their needs.

The lab automation market value is projected to surpass the USD 16 billion mark by end-2022. The major growth drivers include innovative instruments and reagents, improved efficiency and decreases in costs, and latest developments in lab instrumentation, among others. However, the absence of compatibility between systems in a laboratory and challenges in contemporary technologies are threatening the sector’s expansion.

The USA takes the lead in the clinical lab automation market, with Europe and Japan, respectively, following after. Application-wise, Work Station and LIMS grab the lion’s share of the market. Work station is anticipated to lead the market in 2022, with LIMS coming second. Other applications comprise sample transport system and specimen handling system, which are likely to hold the third and fourth positions in the overall clinical lab automation marketplace.

New research study “Lab Automation Market – Global Industry Analysis and Opportunities Assessment 2012 – 2022” prepared DPI Research offers a comprehensive examination of the market, providing deep insights, true facts, historical figures and trustworthy data and forecasts. The report provides a deep analysis and important information on the sector with respect to such categories as market segments, regions, product types and key deals in the lab automation universe. The study provides sizing and 6-year forecasts for the overall market and its segments. It also presents forecasts for the main regional and country markets, by value, – the USA, Europe, Japan, the so-termed BRIC nations and RoW.